 |
Transgene reports positive interim Phase II data from cancer vaccine programme
Thursday, February 12, 2004 09:00 IST
France
The three ongoing trials are designed to assess MVA-Muc1-IL2 in different treatment modalities
Read complete story ...
(You will need to login first to read this story.)
|
|
|
